ELEANOR BOURQUE: Open Payments
NPI 1215596531 · COTTONWOOD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 26 payments from 12 companies in 2025. Trend: 2023 $172 · 2024 $635 · 2025 $659
Food & beverage: $559Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $242 |
| Astellas Pharma US Inc | 1 | $100 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, Kerendia, PREVNAR 20, GEMTESA, Leqembi, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
